Avantor, Inc. Litigation Settlement, Expense
Avantor, Inc. (AVTR) reported Litigation Settlement, Expense of $7.90 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2024-10-25
- Avantor, Inc. litigation settlement, expense for the quarter ending 2024-09-30 was $7.90M, a 163.33% increase year-over-year.
- Avantor, Inc. litigation settlement, expense for the quarter ending 2023-09-30 was $3.00M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 9 month |
|---|---|---|
| 2024-09-30 | $7.90M 10-Q · filed 2024-10-25 | $7.90M 10-Q · filed 2024-10-25 |
| 2023-09-30 | $3.00M 10-Q · filed 2024-10-25 | $4.00M 10-Q · filed 2024-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |